Gaurab Mitra

Liposomal Amphotericin B for Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: 2-Year Treatment Outcomes in Bihar, India

P. K. Sinha, Johan van Griensven, Krishna Pandey et al. · Clinical Infectious Diseases · 2011 · 83 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

Sakib Burza, Prabhat Kumar Sinha, Raman Mahajan et al. · PLoS neglected tropical diseases · 2014 · 67 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +14

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India

Sakib Burza, Prabhat Kumar Sinha, Raman Mahajan et al. · PLoS neglected tropical diseases · 2014 · 65 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)

Sakib Burza, Raman Mahajan, Prabhat Kumar Sinha et al. · PLoS neglected tropical diseases · 2014 · 63 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India

Raman Mahajan, Pradeep Das, Petros Isaakidis et al. · Clinical Infectious Diseases · 2015 · 63 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +15